TherapeuticsMD falls as Q3 revenue misses estimate

TherapeuticsMD

14/11/2022 23:24

** TherapeuticsMD's shares  TXMD.O  fall ~10% to $5.82 after
the bell
    ** Q3 total revenue of $20.9 mln misses analysts' estimate
of $26.8 mln - Refinitiv data
    ** Revenue from its women's contraceptive ring Annovera
falls 12% to $10.4 mln, while its other products also see a
decline
    ** Management continues to "actively assess strategic
alternatives" - co
    ** Up to Monday's close, stock had fallen 64% YTD
 (Reporting by Leroy Leo in Bengaluru)
 ((Leroy.Dsouza@thomsonreuters.com ; Twitter: https://twitter.com/LeroyLeo7;))